152P A phase I study of HBM4003, an anti-CTLA-4 heavy chain only monoclonal antibody, in combination with toripalimab in advanced melanoma. (December 2022) - Bixia, T.; Chi, Z.; Chen, Y.; Jiang, Y.; Fang, M.; Gao, Q.; Huang, G.; Ren, X.; Yao, Y.; Chen, J.; Zhang, X.; Li, R.; et al.